US 12,232,729 B2
Systems for detecting proximity of surgical end effector to cancerous tissue
Frederick E. Shelton, IV, Hillsboro, OH (US); Jason L. Harris, Lebanon, OH (US); and Chad E. Eckert, Milford, OH (US)
Assigned to Cilag GmbH International, Zug (CH)
Filed by Cilag GmbH International, Zug (CH)
Filed on Jun. 6, 2023, as Appl. No. 18/206,392.
Application 18/206,392 is a continuation of application No. 16/024,138, filed on Jun. 29, 2018, granted, now 11,666,331, issued on Jun. 6, 2023.
Claims priority of provisional application 62/691,227, filed on Jun. 28, 2018.
Claims priority of provisional application 62/650,882, filed on Mar. 30, 2018.
Claims priority of provisional application 62/650,877, filed on Mar. 30, 2018.
Claims priority of provisional application 62/650,898, filed on Mar. 30, 2018.
Claims priority of provisional application 62/650,887, filed on Mar. 30, 2018.
Claims priority of provisional application 62/640,417, filed on Mar. 8, 2018.
Claims priority of provisional application 62/640,415, filed on Mar. 8, 2018.
Claims priority of provisional application 62/611,341, filed on Dec. 28, 2017.
Claims priority of provisional application 62/611,340, filed on Dec. 28, 2017.
Claims priority of provisional application 62/611,339, filed on Dec. 28, 2017.
Prior Publication US 2023/0389922 A1, Dec. 7, 2023
Int. Cl. A61B 17/072 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 17/00 (2006.01); A61B 17/29 (2006.01); A61B 17/32 (2006.01); A61B 18/00 (2006.01); A61B 18/12 (2006.01); A61B 18/14 (2006.01); A61B 34/20 (2016.01); A61B 34/37 (2016.01); A61B 90/00 (2016.01); G16H 10/60 (2018.01); G16H 30/20 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01)
CPC A61B 17/07207 (2013.01) [A61B 5/14532 (2013.01); A61B 5/6886 (2013.01); A61B 18/1445 (2013.01); A61B 34/20 (2016.02); A61B 34/37 (2016.02); A61B 90/361 (2016.02); G16H 10/60 (2018.01); G16H 30/20 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); A61B 2017/00017 (2013.01); A61B 2017/00022 (2013.01); A61B 2017/00035 (2013.01); A61B 2017/00119 (2013.01); A61B 2017/00123 (2013.01); A61B 2017/00221 (2013.01); A61B 2017/00398 (2013.01); A61B 2017/00734 (2013.01); A61B 2017/07214 (2013.01); A61B 2017/07257 (2013.01); A61B 2017/07271 (2013.01); A61B 2017/2926 (2013.01); A61B 2017/320097 (2017.08); A61B 2018/00904 (2013.01); A61B 2018/1253 (2013.01); A61B 2018/126 (2013.01); A61B 2090/373 (2016.02); A61B 2217/005 (2013.01); A61B 2217/007 (2013.01); A61B 2218/008 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A surgical instrument, comprising:
an end effector, comprising:
a first jaw;
a second jaw movable relative to the first jaw to grasp tissue therebetween;
an anvil;
a staple cartridge comprising staples deployable into the tissue, wherein the staples are deformable by the anvil;
a first sensor located on a first lateral side of the staple cartridge and configured to provide a first sensor signal according to a physiological parameter of the tissue indicative of proximity of the first sensor to cancerous tissue;
a second sensor located on a second lateral side of the staple cartridge opposite the first side and configured to provide a second sensor signal according to the physiological parameter of the tissue indicative of proximity of the second sensor to cancerous tissue;
a control circuit coupled to the sensor, wherein the control circuit is configured to:
receive the first and second sensor signals; and
detect a presence of a cancerous tissue based on a magnitude of the first sensor signal or the second sensor signal;
determine, in response to a detection of the presence of the cancerous tissue, a direction in which the end effector should be moved to increase a distance of the end effector from the cancerous tissue;
generate an indication of the direction in which the end effector should be moved to increase the distance of the end effector from the cancerous tissue.